Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and β‐amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The up‐regulation of the angiogenic vascular endothelial growth factor (VEGF) in brains of Alzheimer patients in close relationship to β‐amyloid (Aβ) plaques, suggests a link of VEGF action and processing of the amyloid precursor protein (APP). To reveal whether VEGF may affect APP processing, brain slices derived from 17‐month‐old transgenic Tg2576 mice were exposed with 1 ng/ml VEGF for 6, 24, and 72 h, followed by assessing cytosolic and membrane‐bound APP expression, level of both soluble and fibrillar Aβ‐peptides, as well as activities of α‐ and β‐secretases in brain slice tissue preparations. Treatment of brain slices with VEGF did not significantly affect the expression level of APP, regardless of the exposure time studied. In contrast, VEGF exposure of brain slices for 6 h reduced the formation of soluble, SDS extractable Aβ(1–40) and Aβ(1–42) as compared to brain slice cultures incubated in the absence of any drug, while the fibrillar Aβ peptides did not change significantly. This effect was less pronounced 24 h after VEGF exposure, but was no longer detectable when brain slices were exposed by VEGF for 72 h, which indicates an adaptive response to chronic VEGF exposure. The VEGF‐mediated reduction in Aβ formation was accompanied by a transient decrease in β‐secretase activity peaking 6 h after VEGF exposure. To reveal whether the VEGF‐induced changes in soluble Aβ‐level may be due to actions of VEGF on Aβ fibrillogenesis, the fibrillar status of Aβ was examined using the thioflavin‐T binding assay. Incubation of Aβ preparations obtained from Tg2576 mouse brain cortex, in the presence of VEGF slightly decreased the fibrillar content with increasing incubation time up to 72 h. The data demonstrate that VEGF may affect APP processing, at least in vitro, suggesting a role of VEGF in the pathogenesis of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590 · cited 1×
“Functional vascular abnormalities are one of the earlier clinical manifestations in Alzheimer’s disease (AD) (see, e.g., Farkas and Luiten, 2001), and ischemic stroke increases the risk of the disorder (Kalaria, 2000; Kokmen et al., 1996; Snowdon et al., 1997).”
BackgroundCerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · cited 1×
“Functional vascular abnormalities are one of the earlier clinical manifestations in Alzheimer’s disease (AD) (see, e.g., Farkas and Luiten, 2001), and ischemic stroke increases the risk of the disorder (Kalaria, 2000; Kokmen et al., 1996; Snowdon et al., 1997).”
BackgroundKawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 1×
“To differentiate between soluble and fibrillar, plaque-associated Ab a two-step sequential extraction procedure was used as described by Kawarabayashi et al. (2001).”
Methodβ-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · cited 1×
“Cerebrovascular pathology such as cerebral amyloid angio- pathy and endothelial degeneration have been reported in many Alzheimer cases (De la Torre, 2002; Kalaria, 2000; Soffer, 2006; Thomas et al., 1996).”
BackgroundMarti, H. J. H., Bernaudin, M., Bellail, A., Schoch, H., Euler, M., Petit, E., & Risau, W. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64964-4 · Cited by 680 · cited 2×
“The up-regulation of VEGF in response to hypoxic, ischemic or hypoglycemic stress (Marti and Risau, 1998; Marti et al., 2000; Stein et al., 1995; Yancopoulos et al., 2000), suggests its involvement also in processing of the amyloid precursor protein (APP).”
BackgroundEllis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561
Microvascular injury and blood–brain barrier leakage in Alzheimer's disease
Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487
Dementia after ischemic stroke: A population-based study in Rochester, Minnesota (1960-1984)
Kokmen, E., Whisnant, J. P., O'Fallon, W. M., Chu, C.-P., & Beard, C. M. (1996) · Neurology · doi:10.1212/wnl.46.1.154 · Cited by 434
Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360 · cited 4×
“Increased intrathecal levels of VEGF have also been observed in brains of Alzheimer patients as compared to age- matched healthy individuals (Kalaria et al., 1998; Tarkowski et al., 2002; Yang et al., 2004), that has been correlated with the clinical severity of the disease (Ryu et al., 2009).”
BackgroundResultInfluentialIschemic stress induces deposition of amyloid ? immunoreactivity in human brain
Jendroska, K., Poewe, W., Pluess, J., Iwerssen-Schmidt, H., Paulsen, J., Barthel, S., Schelosky, L., Cerv�s-Navarro, J., Daniel, S. E., & DeArmond, S. J. (1995) · Acta Neuropathologica · doi:10.1007/bf00294806 · Cited by 163
Cited by
The cholinergic system in aging and neuronal degeneration
Schliebs, R., & Arendt, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.058 · Cited by 1,047
Self-citationNitric Oxide Signaling in Brain Function, Dysfunction, and Dementia
Steinert, J. R., Chernova, T., & Forsythe, I. D. (2010) · The Neuroscientist · doi:10.1177/1073858410366481 · Cited by 469
Santos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431
Hawkes, C. A., Härtig, W., Kacza, J., Schliebs, R., Weller, R. O., Nicoll, J. A., & Carare, R. O. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0801-7 · Cited by 364
Self-citationBiron, K. E., Dickstein, D. L., Gopaul, R., & Jefferies, W. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023789 · Cited by 300
“in the cortical tissue of 20 month old Tg2576 mice [69] supports”
BackgroundDi Marco, L. Y., Venneri, A., Farkas, E., Evans, P. C., Marzo, A., & Frangi, A. F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.014 · Cited by 262
Diniz, B., Machado-Vieira, R., & Forlenza (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s33086 · Cited by 128
Shen, Y., Ye, B., Chen, P., Wang, Q., Fan, C., Shu, Y., & Xiang, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00394 · Cited by 105
“Exogenous VEGF was administered to transgenic mice by Burger et al. (2009) who found that VEGF modulated β-secreatase1 (BACE1) and reduced soluble Aβ1–40 and Aβ1–42.”
BackgroundThomas, R., Zuchowska, P., Morris, A. W. J., Marottoli, F. M., Sunny, S., Deaton, R., Gann, P. H., & Tai, L. M. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0387-3 · Cited by 72
Paris, D., Ganey, N., Banasiak, M., Laporte, V., Patel, N., Mullan, M., Murphy, S. F., Yee, G.-T., Bachmeier, C., Ganey, C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2586-10.2010 · Cited by 30
“Altogether our data show that the brains of transgenic mouse models of AD overexpressing A do not constitute an adequate environment to sustain angiogenesis despite increased intracerebral levels of angiogenic growth factors (Lopez-Lopez et al., 2007; Bürger et al., 2009).”
BackgroundInfluential
Metadata
- Authors
- Bürger, S., Noack, M., Kirazov, L. P., Kirazov, E. P., Naydenov, C. L., Kouznetsova, E., Yafai, Y., & Schliebs, R.
- Venue
- International Journal of Developmental Neuroscience
- Publisher
- Wiley
- Published
- 2009-07-07
- Volume
- 27
- Issue
- 6
- Pages
- 517-523
- ISSN
- 0736-5748 (ISSN-L)
- 1873-474X
- OpenAlex
- W2065032971
- Cited by
- 42
- References
- 14
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.